Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02034864
Other study ID # P110142
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 17, 2014
Est. completion date October 23, 2017

Study information

Verified date January 2019
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether a standardised osteopathic manipulative treatment is more effective than a placebo of osteopathic manipulative treatment, in sub-acute and chronic non-specific low back pain on functional recovery at 3 months.


Description:

Sub-acute (4-12-week duration) and chronic (more than 3-month duration) non-specific low back pain (LBP) is frequent, disabling and costly. The effectiveness of usual treatments (including pain killers, anti-inflammatory drugs, spinal injections, physiotherapy, spinal traction, transcutaneous electrical nerve stimulation, etc) may be not sufficient, and many patients resort to alternative therapies. Manipulative treatments represent en emerging therapy in this area, although studies assessing their effectiveness are limited and often biased. The purpose of this study is to evaluate the efficacy of two manual therapies on improving functional recovery in sub-acute and chronic non-specific low back pain at 3 months. A standardised osteopathic manipulative treatment is compare to a placebo of osteopathic manipulative treatment.


Recruitment information / eligibility

Status Completed
Enrollment 400
Est. completion date October 23, 2017
Est. primary completion date October 23, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Patient consulting for subacute and chronic non-specific low

- Male or female aged from 18 to 65 years (included)

- Patient can speak and understand French

- Patient giving his informed consent to participate in the study

- Patient affiliated to or beneficiary of social insurance

Exclusion Criteria:

- Specific low-back pain caused by inflammatory, tumoral, infectious disease or a back traumatism in the 3 past months

- History of back surgery and/or vertebral fracture in the previous 6 months

- Presence of a motor impairment related to the reason for consultation

- The patient is a student or a practitioner in manipulative therapies

- Pregnancy

- Inability to understand the process of the study

- The patient is already included in another clinical study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Osteopathic manipulative treatment
A standardized manipulative treatment according to the results of a physical examination including 7 anatomical areas will be given by trained osteopaths during 6 sessions (with an interval of 2 weeks between 2 sessions). Each session will last 45 minutes. Osteopaths will have 3 days of training in standardized manipulative treatment.
Placebo of osteopathic manipulative treatment
A standardized placebo of manipulative treatment consisting in "light touch" and according to the results of a physical examination including 7 anatomical areas will be given by trained osteopaths during 6 sessions (with an interval of 2 weeks between 2 sessions). Each session will last 45 minutes. Osteopaths will have 3 days of training in standardized placebo of manipulative treatment.

Locations

Country Name City State
France CHU Cochin Paris

Sponsors (5)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris Institut National de la Santé Et de la Recherche Médicale, France, Institut Universitaire Romand de Sante au Travail, Sorbonne Paris Cité, University of Paris 5 - Rene Descartes

Country where clinical trial is conducted

France, 

References & Publications (18)

1. Poiraudeau S, Lefèvre-Colau M.-M, Fayad F., Rannou F, Revel M. Lombalgie. Encyclopédie Médico-Chirurgicale 15-840-C-10 (2004)

Andersson GB, Lucente T, Davis AM, Kappler RE, Lipton JA, Leurgans S. A comparison of osteopathic spinal manipulation with standard care for patients with low back pain. N Engl J Med. 1999 Nov 4;341(19):1426-31. — View Citation

Assendelft WJ, Morton SC, Yu EI, Suttorp MJ, Shekelle PG. Spinal manipulative therapy for low back pain. A meta-analysis of effectiveness relative to other therapies. Ann Intern Med. 2003 Jun 3;138(11):871-81. Review. — View Citation

Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P; CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008 Feb 19;148(4):295-309. — View Citation

Bronfort G, Haas M, Evans RL, Bouter LM. Efficacy of spinal manipulation and mobilization for low back pain and neck pain: a systematic review and best evidence synthesis. Spine J. 2004 May-Jun;4(3):335-56. Review. — View Citation

Chou R, Huffman LH; American Pain Society; American College of Physicians. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med. 2007 Oct 2;147(7):505-14. Review. Erratum in: Ann Intern Med. 2008 Feb 5;148(3):247-8. — View Citation

Costa LO, Maher CG, Latimer J, Hodges PW, Herbert RD, Refshauge KM, McAuley JH, Jennings MD. Motor control exercise for chronic low back pain: a randomized placebo-controlled trial. Phys Ther. 2009 Dec;89(12):1275-86. doi: 10.2522/ptj.20090218. Epub 2009 Nov 5. — View Citation

Hayden JA, van Tulder MW, Malmivaara AV, Koes BW. Meta-analysis: exercise therapy for nonspecific low back pain. Ann Intern Med. 2005 May 3;142(9):765-75. — View Citation

Hoehler FK, Tobis JS, Buerger AA. Spinal manipulation for low back pain. JAMA. 1981 May 8;245(18):1835-8. — View Citation

Lambeek LC, van Mechelen W, Knol DL, Loisel P, Anema JR. Randomised controlled trial of integrated care to reduce disability from chronic low back pain in working and private life. BMJ. 2010 Mar 16;340:c1035. doi: 10.1136/bmj.c1035. — View Citation

Licciardone JC, Brimhall AK, King LN. Osteopathic manipulative treatment for low back pain: a systematic review and meta-analysis of randomized controlled trials. BMC Musculoskelet Disord. 2005 Aug 4;6:43. Review. — View Citation

Licciardone JC, Stoll ST, Fulda KG, Russo DP, Siu J, Winn W, Swift J Jr. Osteopathic manipulative treatment for chronic low back pain: a randomized controlled trial. Spine (Phila Pa 1976). 2003 Jul 1;28(13):1355-62. — View Citation

Lindell O, Johansson SE, Strender LE. Subacute and chronic, non-specific back and neck pain: cognitive-behavioural rehabilitation versus primary care. A randomized controlled trial. BMC Musculoskelet Disord. 2008 Dec 30;9:172. doi: 10.1186/1471-2474-9-172. — View Citation

Macario A, Pergolizzi JV. Systematic literature review of spinal decompression via motorized traction for chronic discogenic low back pain. Pain Pract. 2006 Sep;6(3):171-8. Review. — View Citation

Manheimer E, White A, Berman B, Forys K, Ernst E. Meta-analysis: acupuncture for low back pain. Ann Intern Med. 2005 Apr 19;142(8):651-63. Review. Erratum in: Ann Intern Med. 2005 Jun 7;142(11):950-1. — View Citation

Nelemans PJ, de Bie RA, de Vet HC, Sturmans F. WITHDRAWN: Injection therapy for subacute and chronic benign low-back pain. Cochrane Database Syst Rev. 2007 Jul 18;(2):CD001824. Review. — View Citation

Rubinstein SM, van Middelkoop M, Kuijpers T, Ostelo R, Verhagen AP, de Boer MR, Koes BW, van Tulder MW. A systematic review on the effectiveness of complementary and alternative medicine for chronic non-specific low-back pain. Eur Spine J. 2010 Aug;19(8):1213-28. doi: 10.1007/s00586-010-1356-3. Epub 2010 Mar 14. Review. — View Citation

Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010 Mar 23;340:c332. doi: 10.1136/bmj.c332. — View Citation

* Note: There are 18 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Mean improvement from baseline in mean activity limitation Assessed with the self-administered Quebec functional scale (from 0, no limitation to 100, maximal limitation) 3 months after randomization
Secondary Mean reduction from baseline in mean lumbar pain in the previous 48 hrs assessed with a self-administered 11-class numeric scale (from 0 no pain to 100, maximal pain) 3 months after randomization
Secondary Mean reduction from baseline in mean lumbar pain in the previous 48 hrs assessed with a self-administered 11-class numeric scale (from 0, no pain to 100, maximal pain) 12 months after randomization
Secondary Number of sick leaves self-reported number of sick leaves 12 months after randomization
Secondary Duration of sick leaves self-reported total duration (days) of sick leaves 12 months after randomization
Secondary Recurrence of pain self-reported number of low back pain episodes 12 months after randomization
Secondary Mean improvement from baseline in mean activity limitation Assessed with the self-administered Quebec functional scale (from 0, no limitation to 100, maximal limitation) 12 months after randomization
Secondary Mean improvement from baseline in mean quality of life Assessed with the physical and mental components of the self-administered MOS SF-12 questionnaire (from 0, worse quality of life to 100, best quality of life) 3 months after randomization
Secondary Mean improvement from baseline in mean quality of life Assessed with the physical and mental components of the self-administered MOS SF-12 questionnaire (from 0, worse quality of life to 100, best quality of life) 12 months after randomization
Secondary Pain killer and non-steroidal anti-inflammatory drug consumption self-reported consumption of pain killer and non-steroidal anti-inflammatory drugs since last contact ( yes/no) 3 months after randomization
Secondary Pain killer and non-steroidal anti-inflammatory drug consumption self-reported consumption of pain killer and non-steroidal anti-inflammatory drugs since last contact ( yes/no) 12 months after randomization